ClinVar Miner

Submissions for variant NM_182914.3(SYNE2):c.20423C>T (p.Ser6808Leu)

gnomAD frequency: 0.00001  dbSNP: rs372922867
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV001057188 SCV000387626 benign Emery-Dreifuss muscular dystrophy 5, autosomal dominant 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001057188 SCV001221668 likely benign Emery-Dreifuss muscular dystrophy 5, autosomal dominant 2024-03-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV004021598 SCV003721168 uncertain significance not specified 2022-11-21 criteria provided, single submitter clinical testing The c.20423C>T (p.S6808L) alteration is located in exon 114 (coding exon 113) of the SYNE2 gene. This alteration results from a C to T substitution at nucleotide position 20423, causing the serine (S) at amino acid position 6808 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003417990 SCV004113366 likely benign SYNE2-related disorder 2024-04-25 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.